Mast‐cell—leukocyte cytokine cascades in allergic inflammation

Allergy: European Journal of Allergy and Clinical Immunology - Tập 50 Số 11 - Trang 851-862 - 1995
Stephen J. Galli1, John J. Costa2
1Department of Pathology, Beth Israel Hospital, Boston, MA 02215, USA
2Departments of Pathology, Beth Israel Hospital, and Harvard Medical School, Boston, MA 02215, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1038/367183a0

Abe Y, 1990, Vascular hyperpermeability induced by tumor necrosis factor and us augmentation by IL‐1 and IFN‐gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody, J Immunol, 145, 2902, 10.4049/jimmunol.145.9.2902

10.1016/0140-6736(92)91646-P

Arock M, 1993, IL‐4 release by human leukemic and activated normal basophils, J Immunol, 151, 1441, 10.4049/jimmunol.151.3.1441

10.1073/pnas.91.21.10089

Barnes PJ., 1993, Allergy: principles and practice, 243

10.1056/NEJM199503303321307

10.1016/0167-5699(93)90167-J

Benyon RC, 1991, Tumor necrosis factor‐α, dependent cytotoxicity of human skin mast cells is enhanced by anti‐IgE antibodies, J Immunol, 147, 2253, 10.4049/jimmunol.147.7.2253

10.1146/annurev.iy.07.040189.003205

Bevilacqua MP., Endothelial‐leukocyte adhesion molecules, Annu Rev immunol, 193, 767

10.1172/JCI116210

10.1084/jem.175.5.1285

Bienenstock J, 1986, Mast cell differentiation and heterogeneity, 391

10.1016/0091-6749(94)90195-3

Borish L, 1991, IgE‐dependent cytokine production by human peripheral blood mononuclear phagocytes, J Immunol, 146, 63, 10.4049/jimmunol.146.1.63

10.1159/000236980

10.1084/jem.176.5.1381

10.1165/ajrcmb.10.5.8179909

10.1165/ajrcmb/3.5.507

10.1016/0091-6749(91)90158-K

10.1016/0091-6749(92)90218-Q

10.1084/jem.177.3.605

10.1084/jem.170.1.245

10.1056/NEJM198902023200502

Busse WW, 1993, Allergy: principles and practice, 1173

10.1016/0092-8674(90)90298-S

Costa JJ, Clinical immunology, principles and practice

10.1172/JCI116506

10.1016/S0140-6736(94)90628-9

Ellis EF., 1993, Allergy principles and practice, 1225

Enlrbäck L., 1986, Mast cell differentiation and heterogeneity, 1

Finotto S, 1994, TNE‐α production by eosinophils in upper airways inflammation (nasal polyposis), J Immunol, 153, 2278, 10.4049/jimmunol.153.5.2278

10.1097/00003246-199303000-00006

Galli SJ., 1990, Biology of disease. New insights into “the riddle of the mast cells” microenvironmental regulation of mast cell development and phenotypic heterogeneity, Lab Invest, 62, 5

10.1056/NEJM199301283280408

Galli SJ, 1992, The role of the mast cell in health and disease, 129

Galli SJ, 1994, Eosinophils: immunological and clinical aspects, 255

Galli SJ, 1987, Animal model of human disease. Genetically mast cell‐deficient WW and Sl Sld mice: their value for the analysis of the roles of mast cells in biological responses in vivo, Am J Pathol, 127, 191

10.1165/ajrcmb.11.6.7524569

10.1002/9780470513866.ch5

10.1016/S0065-2776(08)60508-8

10.1038/365340a0

10.7326/0003-4819-121-9-199411010-00011

10.1016/0167-5699(90)90176-A

10.1038/346274a0

10.1084/jem.174.1.103

10.1084/jem.180.6.2027

Gordon JR, 1991, Characterization of mouse most cell TNF‐α induction in vitro and in viva and demonstration that purified human lung mast cells contain TNE‐α, FASEB J, 5, A1009

Gosset P, 1990, Induction of TNE release by alveolar macrophages after allergen challenge in asthmatic patients: correlation with the late phase reaction, Am Rev Respir Dis, 141, A677

Gutierrez HH, 1995, et al Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators, Am J Physiol, 268, L501

Ha TY, 1987, Systemic anaphylaxis in mast cell‐deficient mice of W W and Sl Sld genotypes, Exp Cell Biol, 55, 63

10.1159/000234031

Hatfield SM, 1992, Cyolosporin and FK506 inhibition of marine mast cell cytokine production, J Pharmacol Exp Ther, 260, 680

Holgate ST, 1993, Allergy: principles and practice, 267

10.1016/0092-8674(90)90303-V

Hültner L, 1994, IL‐I up‐regulates expression of IL‐2 and IL‐3 as well as TH 2‐type cytokines (IL‐5, IL‐6, IL‐9, IL‐13) in activated mouse bone marrow‐derived mast cells, J Invest Dermatol, 103, 620

Irani A‐MA., 1990, Neutral proteases as indicators of human mast cell heterogeneity, Monogr Allergy, 27, 146

10.1111/1523-1747.ep12340431

10.1111/j.1398-9995.1994.tb01119.x

10.1073/pnas.89.18.8542

10.1016/0952-7915(92)90122-U

10.1164/ajrccm/145.2_Pt_1.332

Kitamura Y., 1989, Heterogeneity of mast cells and phenotypic changes between subpopulations, Annu Rev Immunol, 127, 191

10.1073/pnas.86.22.8972

10.1016/0167-5699(91)90107-5

10.1084/jem.176.6.1773

10.1165/ajrcmb.12.4.7695919

10.1164/ajrccm/147.3.697

10.1084/jem.180.3.807

10.1172/JCI115201

MacGlashan DW, 1994, Secretion of inlerleukin‐4 from human basophils: the relationship between IL‐4 mRNA and protein in resting and stimulated basophils, J Immunol, 152, 3006, 10.4049/jimmunol.152.6.3006

Martin TR, 1993, Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice, J Immunol, 151, 367, 10.4049/jimmunol.151.1.367

10.1172/JCI116277

10.1084/jem.179.2.745

10.1084/jem.182.1.197

10.1164/ajrccm/144.3_pt_2.S48

10.1084/jem.162.3.1025

10.1038/370367a0

10.1165/ajrcmb/7.4.385

10.1172/JCI115764

Panettieri RA, 1995, Activation of cAMP‐dependent pathways in human airway smooth muscle cells inhibits TNF‐α‐induced ICAM‐1 and Vcam‐1 expression and T lymphocyte adhesion, J Immunol, 154, 2358, 10.4049/jimmunol.154.5.2358

10.1136/thx.50.4.328

10.1016/0092-8674(89)90121-9

10.1016/0092-8674(94)90332-8

10.1172/JCI115853

10.1038/339064a0

10.1111/j.1398-9995.1994.tb00122.x

10.1016/S0140-6736(54)91417-8

10.1006/bbrc.1994.2169

10.1006/bbrc.1994.1119

10.1136/thx.48.8.845

10.1164/ajrccm/148.2.401

10.1016/0167-5699(91)90120-I

10.1016/0167-5699(92)90083-J

10.1084/jem.176.6.1489

10.1084/jem.177.6.1821

10.1016/S0960-9822(94)00032-1

Schleimer RP., 1993, Allergy: principles and practice, 893

10.1164/ajrccm/145.2_Pt_2.S18

10.1073/pnas.88.7.2835

10.1172/JCI113855

10.1038/359693a0

10.1159/000236767

Sommerhoff CP., 1995, Mast cell proteases in immunology and biology, 145

10.1016/0092-8674(94)90337-9

Sur S, 1993, Allergy: principles and practice, 169

10.1038/366421a0

10.1172/JCI115344

10.1159/000237056

Taubbb DD, 1993, Biology of the inflammatory peptide supergene family II, 139

Tsai M, 1990, Mast cells constitutively express transforming growth factor β mRNA, FASEB J, 4, A1944

10.1146/annurev.iy.10.040192.002211

Vercelli D, 1993, Allergy: principles and practice, 93

10.1073/pnas.88.10.4220

10.1084/jem.175.5.1353

10.1111/j.1398-9995.1994.tb00778.x

10.1056/NEJM199104183241607

Wershil BK, 1995, Dexamethasone or cyclosporin A suppresses mast cell‐leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE‐ and mast cell‐dependent cutaneous inflammation in the mouse, J Immunol, 154, 1391, 10.4049/jimmunol.154.3.1391

Wershil BK, 1987, 125I‐Fibrin deposition in IgE‐dependent immediate hyper‐sensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell‐deficient mice locally reconstituted with cultured mast cells, J Immunol, 139, 2605, 10.4049/jimmunol.139.8.2605

10.1172/JCI115016

Witham BA., 1995, JAX Notes. No. 461

10.1016/0092-8674(90)90280-R

10.1038/339150a0

10.1182/blood.V78.10.2702.2702

10.1165/ajrcmb.12.5.7742012

10.1111/j.1365-2222.1991.tb03205.x

10.1073/pnas.84.24.9175

10.1016/0092-8674(90)90302-U